Broader Financial Turmoil Threatens Biotech’s Innovation and Cash
Wednesday, October 29, 2008 - 05:14
in Mathematics & Economics
Biotech companies, some of the riskiest stock around because most experimental drugs fail, have been negatively impacted by the financial crisis.